{
  "data": {
    "indicator": {
      "slug": "bioequivalence-trials-share",
      "name": "Bioequivalence trials share",
      "definition": "Share of bioequivalence trials in total registered clinical trials.",
      "unit": "percent",
      "scale": "1",
      "default_unit": "percent",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "percent",
    "region": {
      "code": "CN",
      "name": "China",
      "type": "country"
    },
    "points": [
      {
        "period_start": "2025-01-01",
        "period_label": "2025",
        "value": 42.5,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_HEBDQ5W4X21WJNF05KTYPFNKZQ",
        "url": "https://statorigin.org/stat/stat_HEBDQ5W4X21WJNF05KTYPFNKZQ",
        "source_org": "NHSA",
        "source": {
          "org": "National Healthcare Security Administration",
          "org_short_name": "NHSA",
          "document_title": "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升",
          "document_url": "http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html",
          "locator": "试验包括新药临床试验和生物等效性试验",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "CN"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}